Latest News in the pharma Industry

Research & Development

Lilly's Taltz receives FDA approval for the treatment of moderate-to-severe plaque psoriasis

Lilly's Taltz receives FDA approval for the treatment of moderate-to-severe plaque psoriasis

23 Mar 2016

In pivotal studies, most patients treated with Taltz achieved significant skin clearance with many achieving virtually clear or completely clear skin at week 12.

Read more 
Eagle Pharmaceuticals receives Complete Response Letter from FDA on Kangio application

Eagle Pharmaceuticals receives Complete Response Letter from FDA on Kangio application

20 Mar 2016

FDA requests further characterization of bivalirudin-related substances in the drug product.

Read more 
RedHill Biopharma announces positive FDA meeting on RHB-105 path to approval and planned confirmatory Phase III study for H. pylori infection

RedHill Biopharma announces positive FDA meeting on RHB-105 path to approval and planned confirmatory Phase III study for H. pylori infection

18 Apr 2016

The FDA has confirmed, subject to final minutes of the meeting, the planned two-arm, randomized, double-blind, active comparator design of the confirmatory Phase III study with RHB-105 for the treatment of H. pylori infection, expected to be initiated ...

Read more 
GSK and Miltenyi Biotec establish cell and gene therapy collaboration

GSK and Miltenyi Biotec establish cell and gene therapy collaboration

18 Mar 2016

Collaboration includes discovery programme for CAR-T cell-based oncology therapies.

Read more 
BMS to present new overall survival data for Opdivo as monotherapy and in combination with Yervoy at AACR 2016 Annual Meeting

BMS to present new overall survival data for Opdivo as monotherapy and in combination with Yervoy at AACR 2016 Annual Meeting

18 Mar 2016

New, pivotal Phase III overall survival data from CheckMate -141 for Opdivo in previously treated advanced squamous cell carcinoma of the head and neck, to be presented.

Read more 
Experimental dengue vaccine protects all recipients in virus challenge study

Experimental dengue vaccine protects all recipients in virus challenge study

17 Mar 2016

Vaccine developed by NIH and FDA scientists.

Read more 
Monoclonal antibodies headline innovation in gastric cancer treatment pipeline

Monoclonal antibodies headline innovation in gastric cancer treatment pipeline

17 Mar 2016

GBI Research says pipeline consists of 29% monoclonal antibodies.

Read more 
FDA grants Genentech’s cancer immunotherapy atezolizumab Priority Review for advanced bladder cancer

FDA grants Genentech’s cancer immunotherapy atezolizumab Priority Review for advanced bladder cancer

15 Mar 2016

FDA will make a decision on approval by 12 September 2016.

Read more 
FDA approves Xalkori for the treatment of patients with ROS1-positive metastatic NSCLC

FDA approves Xalkori for the treatment of patients with ROS1-positive metastatic NSCLC

13 Mar 2016

Xalkori is the first and only FDA-approved biomarker-driven therapy for ROS1-positive metastatic NSCLC.

Read more 
PhoreMost and The Wistar Institute collaborate to identify new druggable targets in cancer, immunotherapy and ageing

PhoreMost and The Wistar Institute collaborate to identify new druggable targets in cancer, immunotherapy and ageing

10 Mar 2016

Collaboration will use Siteseeker — a new ‘phenotypic’ screening platform that exploits the dynamics of a live-cell environment to uncover hidden druggable target sites across the entire human genome — to find new therapeutic options.

Read more 
EMA launches PRIME — paving the way for promising medicines for patients

EMA launches PRIME — paving the way for promising medicines for patients

8 Mar 2016

New scheme supports European Commission priorities.

Read more 
New understanding of the mechanism of neurodegeneration leads to a novel approach to treatment for Alzheimer’s disease

New understanding of the mechanism of neurodegeneration leads to a novel approach to treatment for Alzheimer’s disease

7 Mar 2016

Innovative drug prototype shown to block damaging activity in human cell lines suggests a promising strategy for future therapeutics.

Read more